OUTPATENT VASODILATOR ASSESSMENT USING ILOPROST IN PULMONARY HYPERTENSION (The OVATION Study)
Phase of Trial: Phase IV
Latest Information Update: 09 Sep 2018
At a glance
- Drugs Iloprost (Primary) ; Nitric oxide
- Indications Pulmonary hypertension
- Focus Diagnostic use
- Acronyms OVATION
- 21 Jul 2017 Status changed from not yet recruiting to recruiting.
- 01 Jun 2017 Planned End Date changed from 1 Oct 2018 to 1 Dec 2019.
- 01 Jun 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Dec 2018.